4D Molecular Therapeutics Inc (33) | Human Resources (14)
Browse by Subcategory
Recent Contracts
-
Amended and Restated Non-Employee Director Compensation Policy
(Filed With SEC on May 12, 2022)
-
Change in Control and Severance Agreement, dated September 22, 2021, by and between Fred Kamal and 4D Molecular Therapeutics, Inc
(Filed With SEC on November 10, 2021)
-
2020 Incentive Award Plan
(Filed With SEC on December 7, 2020)
-
Employment Agreement, dated January 15, 2019 between Peter Francis, M.D., Ph.D. and the Registrant
(Filed With SEC on December 7, 2020)
-
Change in Control and Severance Agreement, dated September 22, 2021, by and between August Moretti and 4D Molecular Therapeutics, Inc
(Filed With SEC on September 24, 2021)
-
Change in Control and Severance Agreement, dated September 22, 2021, by and between David Kirn and 4D Molecular Therapeutics, Inc
(Filed With SEC on September 24, 2021)
-
Change in Control and Severance Agreement, dated September 22, 2021, by and between Robert Stephen Fishman and 4D Molecular Therapeutics, Inc
(Filed With SEC on September 24, 2021)
-
Form of Stock Option Grant Notice and Stock Option Agreement under the 2020 Incentive Award Plan
(Filed With SEC on December 7, 2020)
-
Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement under the 2020 Incentive Award Plan
(Filed With SEC on December 7, 2020)
-
Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2020 Incentive Award Plan
(Filed With SEC on December 7, 2020)
-
2015 Equity Incentive Plan
(Filed With SEC on November 17, 2020)
-
Form of Stock Option Agreement under 2015 Equity Incentive Plan
(Filed With SEC on November 17, 2020)
-
2015 Equity Incentive Plan
(Filed With SEC on September 30, 2019)
-
Form of Stock Option Agreement under 2015 Equity Incentive Plan
(Filed With SEC on September 30, 2019)